Clopidogrel

Major

Clopidogrel Acetaminophen And Codeine Capital® & Codeine Explained Reduced efficacy of clopidogrel Details Clopidogrel Omeprazole Gastrobim Reduced clopidogrel active metabolite exposure and decreased antiplatelet activity Details Clopidogrel Sertraline An increased risk of bleeding Details Clopidogrel Buprenorphine Belbuca Reduced efficacy of clopidogrel Details Clopidogrel Relugolix Orgovyx Increased relugolix exposure Details Clopidogrel Apixaban Eliquis Increased risk of bleeding and can cause serious, potentially fatal bleeding Details Clopidogrel Aspirin Acuprin® An increased risk of bleeding Details Clopidogrel Aspirin Rectal Aspirin An increased risk of bleeding Details Clopidogrel Azathioprine Azasan An increased risk of hepatotoxicity Details Clopidogrel Betrixaban Bevyxxa® Increased risk of bleeding Details Clopidogrel Amlodipine Amvaz® Decreased antiplatelet effect and increased risk of thrombotic events Details Clopidogrel Anagrelide Agrylin Increased bleeding risk Details Clopidogrel Bromfenac Ophthalmic Bromday® An increased risk of bleeding Details Clopidogrel Butorphanol Injection Butorphic Reduced efficacy of clopidogrel Details Clopidogrel Butorphanol Nasal Spray Stadol® NS Reduced efficacy of clopidogrel Details Clopidogrel Caplacizumab-Yhdp Injection Cablivi An increased risk of bleeding Details Clopidogrel Abciximab An increased risk of bleeding Details Clopidogrel Aceclofenac An increased risk of bleeding Details Clopidogrel Acemetacin An increased risk of bleeding Details Clopidogrel Acenocoumarol Increased risk of bleeding Details Clopidogrel Alfentanil Reduced efficacy of clopidogrel Details Clopidogrel Alipogene Tiparvovec An increased risk of bleeding Details Clopidogrel Alteplase, Recombinant Activase An increased risk of bleeding Details Clopidogrel Amiodarone Nexterone Increased amiodarone exposure Details Clopidogrel Amtolmetin Guacil An increased risk of bleeding Details Clopidogrel Anileridine Reduced efficacy of clopidogrel Details Clopidogrel Apalutamide Erleada Increased clopidogrel active metabolite exposure, an increased platelet inhibition and reduced clopidogrel exposure Details Clopidogrel Ardeparin Increased risk of bleeding Details Clopidogrel Argatroban Increased risk of bleeding Details Clopidogrel Atazanavir Reyataz Reduced clopidogrel (active metabolite) exposure and reduced efficacy of clopidogrel Details Clopidogrel Belzutifan Welireg Increased belzutifan exposure and an increased risk of belzutifan-related adverse reactions Details Clopidogrel Bemiparin Increased risk of bleeding Details Clopidogrel Benzhydrocodone Reduced efficacy of clopidogrel Details Clopidogrel Bivalirudin Angiomax Increased risk of bleeding Details Clopidogrel Bromfenac Bromsite An increased risk of bleeding Details Clopidogrel Bufexamac An increased risk of bleeding Details Clopidogrel Bupropion Aplenzin Increased buPROPion exposure, reduced hydroxybuPROPion exposure Details Clopidogrel Butorphanol Butorphic Reduced efficacy of clopidogrel Details Clopidogrel Cangrelor Kengreal An increased risk of bleeding Details Clopidogrel Caplacizumab-Yhdp An increased risk of bleeding Details